Join our journey
A Norwegian life-science company solving one of the largest medical challenges we are facing.
20 minutes delay

Lifecare as an investment

Lifecare’s purpose is to develop and license technology for medical use, including facilitating the production and sale of medical devices. Today people with diabetes are dependent on a painful and more than 40-year-old technology. Lifecare’s solutions have the potential to revolutionise the field of continuous glucose measurement for more the more than 530 million people living with diabetes.

 

Top 5 shareholders

Updated October 3, 2023
Name
Holdings
Share
Citizen
Teigland Eiendom AS
24 691 829
20.95 %
NOR
Lacal AS
18 187 712
15.43 %
NOR
VPF Nordea Avkastning
8 770 413
7.44 %
NOR
Spit Air AS
3 087 735
2.62 %
NOR
Patricia Rodrigues Da Costa Sandquist
2 870 000
2.43 %
NOR
Swipe for more data

Contact

Investor relations